US Distributor Demands Better Biosimilars Support

 
• By Aidan Fry
  
Generate a summary of this article
Listen to this article
Beta

Removing legal hurdles and putting biosimilars on preferred formulary tiers will increase access and cut the cost of biologic therapies in the US, argues the chief of major healthcare distributor AmerisourceBergen.

Amerisource
AmerisourceBergen boss Steve Collis argues that US policymakers must give better support to biosimilars • Source: Shutterstock

A more supportive system is needed to drive greater uptake of biosimilars and generate healthcare savings in the US, according to a letter sent to the Wall Street Journal by AmerisourceBergen’s chairman, president and CEO Steve Collis. The letter from the chief of the US distributor is the latest in a string of responses to an opinion piece in which oncologist Peter Bach and colleague Mark Trusheim suggested it was time to “throw in the towel” on biosimilars in the US and focus on controlling prices of off-patent biologic originals.

“If we remove legal hurdles, push for preferred formulary status and establish a clearer path to interchangeability, we can facilitate...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.